HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glaucia Vilar-Pereira Selected Research

Bradycardia

1/2020CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Glaucia Vilar-Pereira Research Topics

Disease

11Infections
04/2023 - 10/2012
9Heart Diseases (Heart Disease)
01/2022 - 01/2014
8Cardiomyopathies (Cardiomyopathy)
04/2023 - 06/2014
6Chagas Disease (American Trypanosomiasis)
05/2024 - 11/2014
4Fibrosis (Cirrhosis)
01/2023 - 01/2016
3Heart Injuries
01/2020 - 01/2015
2Necrosis
01/2023 - 06/2014
2Memory Disorders (Memory Loss)
01/2023 - 01/2021
2Sinus Arrhythmia
01/2019 - 10/2016
2Myocarditis (Carditis)
10/2016 - 01/2016
1Parasitemia
05/2024
1Neuroinflammatory Diseases
01/2023
1Atrophy
01/2023
1Chagas Cardiomyopathy
01/2021
1Persistent Infection
01/2020
1Bradycardia
01/2020
1Weight Loss (Weight Reduction)
12/2015
1Hypertrophy
03/2015
1Autonomic Nervous System Diseases (Dysautonomia)
11/2014
1Cardiac Arrhythmias (Arrythmia)
11/2014
1Atrioventricular Block
01/2014
1Meningoencephalitis
10/2012

Drug/Important Bio-Agent (IBA)

6benzonidazole (benznidazole)IBA
05/2024 - 01/2016
3Pentoxifylline (Trental)FDA LinkGeneric
01/2023 - 03/2015
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 10/2012
2CytokinesIBA
01/2023 - 01/2021
2Therapeutic UsesIBA
01/2022 - 01/2019
2Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2014
2Connexin 43 (Connexin43)IBA
01/2019 - 03/2015
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2016 - 06/2014
2Fibronectins (Fibronectin)IBA
03/2015 - 01/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024
1Amiodarone (Amiodarona)FDA LinkGeneric
05/2024
1KininsIBA
04/2023
1Bradykinin B1 ReceptorIBA
04/2023
1DNA (Deoxyribonucleic Acid)IBA
04/2023
1MicroRNAs (MicroRNA)IBA
01/2023
1Monoclonal AntibodiesIBA
01/2022
1Transforming Growth Factor beta (TGF-beta)IBA
01/2022
1Chemotactic FactorsIBA
01/2021
1Interleukin-2 (IL2)IBA
01/2021
1CC ChemokinesIBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1Met- RANTESIBA
01/2020
1CCR1 ReceptorsIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
14- (4- (3- (pyridin- 2- yl)- 1H- pyrazol- 4- yl)pyridin- 2- yl)- N- (tetrahydro- 2H- pyran- 4- yl)benzamideIBA
01/2019
1tempolIBA
10/2016
1Metformin (Glucophage)FDA LinkGeneric
10/2016
1AntioxidantsIBA
10/2016
1ResveratrolIBA
10/2016
1SandIBA
12/2015
1VaccinesIBA
01/2015
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2014
1Cholinergic Agents (Cholinergics)IBA
11/2014
1Cholinergic ReceptorsIBA
11/2014
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2014
1AntibodiesIBA
11/2014
1Infliximab (Remicade)FDA Link
01/2014
1Antiparasitic Agents (Antiparasitics)IBA
10/2012
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
10/2012

Therapy/Procedure

8Therapeutics
05/2024 - 01/2015
1Investigational Therapies (Experimental Therapy)
10/2016
1Combination Drug Therapy (Combination Chemotherapy)
01/2016